Tatos is working on the Clp protease system of Mycobacterium tuberculosis (Mtb) – a high priority target for drug development.
Emmy handles managerial responsibilities for the lab. These include ordering supplies, managing safety trainings, maintaining equipment, and shipping materials to collaborators.
Kristi (not a slave to fashion) Guinn has been keenly interested in TB since 2000. She did her Master’s work studying genetic determinants of pathogenicity, and migrated away from the bench shortly thereafter to try her hand at project management. She has happily remained in this capacity, joining the Rubin Lab in 2011.
Olga is working on the Clp protease system of Mycobacterium tuberculosis (Mtb) – a high priority target for drug development.
Mohlopheni (Jackson) is interested in host factors that drive lung granuloma progression in TB patients. He is also interested in genes utilized by M. tuberculosis to subvert macrophage killing effects. Office: University of Cape Town, Cape Town, South Africa
Kerry is studying the characteristics and genes involved in the development of Mycobacterium abscessus biofilms.
Jess joined the Rubin Lab in 2009 and has been involved with multiple projects since then, but has mainly contributed to work investigating genes that are essential for growth in M. tuberculosis, with a special focus on potential drug targets.
Mark is studying Mycobacterium abscessus lung infection through the use of tissue culture model systems.
Ian’s research focuses on genes of unknown function in tuberculosis.
Harry is studying targeted protein degradation as a Mycobacterium tuberculosis antibiotic development strategy.
Office: Chinese Academy of Sciences, Beijing, China
Junhao targets specific, high throughput anti-TB small molecule screening using a DNA encoded drug library and synthetic mitochondria.